Founded 2019
Founders Praapti Jayaswal, CEO, AarogyaAI Avlokita Tiwari, CTO, AarogyaAI

AarogyaAI enables precision medicine for anti-microbial resistance in infectious disease by unlocking the power of genomics and artificial intelligence. Tuberculosis is the most lethal infectious disease, globally. Drug-resistant TB and its delayed diagnosis, exacerbate the problem.

AarogyaAI’s drug susceptibility test ensures patients are prescribed the most effective drugs, 100X faster than the existing gold standard.

The company is backed by the largest genomics company in the world, Illumina Inc. as part of the Illumina Accelerator Program at San Francisco, USA. The Minister of Health, Govt. of India, Startup India, BIRAC amongst others in the Indian Ecosystem have recognized and awarded the innovation.


Founders

Praapti
Jayaswal

CEO, AarogyaAI

Molecular and microbiologist combatting anti-microbial resistance

Linkedin

Avlokita
Tiwari

CTO, AarogyaAI

Bioinformatician with expertise in computational biology and genomic data

Linkedin

Related

47 Labs

47 Labs

Lighting up the brain for healthcare.
A&B Smart Materials

A&B Smart Materials

Revolutionising cooling technology through the development of novel, smart hydrogels.
Accelerated Dynamics

Accelerated Dynamics

Technology to drive the 4th industrial revolution.
AccuRx

AccuRx

Powering communications in the healthcare sector.
Ackcio

Ackcio

Extremely reliable, wireless monitoring solutions for the world's most challenging industries.
Adbrain

Adbrain

Unlocking the universe of data to build smarter businesses.